Vanguard Fiduciary Trust’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
366,541
+14,075
+4% +$306K ﹤0.01% 1789
2026
Q1
$6.12M Buy
+352,466
New +$6.67M ﹤0.01% 1971

Other funds holding CDNA

Vanguard Fiduciary Trust's CDNA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its CareDx (CDNA) stake by 4% in Q2 2026, buying an estimated $306K and bringing the position to 366,541 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

Vanguard Fiduciary Trust first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Vanguard Fiduciary Trust held 366,541 shares of CareDx worth $10.4M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 14,075 CareDx shares in Q2 2026, an estimated $306K.
  • CareDx made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1789 holding.
  • Vanguard Fiduciary Trust first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
  • 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.